Journal ArticleJ Am Heart Assoc · October 20, 2020
Background Despite investments to improve quality of emergency care for patients with acute myocardial infarction (AMI), few studies have described national, real-world trends in AMI care in the emergency department (ED). We aimed to describe trends in the ...
Full textOpen AccessLink to itemCite
Journal ArticleTexas Heart Institute Journal · February 1, 2017
Pump thrombosis is a dire sequela after left ventricular assist device (LVAD) implantation. Treatment comprises antiplatelet agents, anticoagulants, thrombolytic agents, and pump exchange. Although pump exchange is the definitive therapy, it is als ...
Full textCite
Journal ArticleJ Am Heart Assoc · October 20, 2020
Background Despite investments to improve quality of emergency care for patients with acute myocardial infarction (AMI), few studies have described national, real-world trends in AMI care in the emergency department (ED). We aimed to describe trends in the ...
Full textOpen AccessLink to itemCite
Journal ArticleTexas Heart Institute Journal · February 1, 2017
Pump thrombosis is a dire sequela after left ventricular assist device (LVAD) implantation. Treatment comprises antiplatelet agents, anticoagulants, thrombolytic agents, and pump exchange. Although pump exchange is the definitive therapy, it is als ...
Full textCite
Journal ArticleCirculation · September 8, 2009
Background—
Three-fourths of cardiac arrest survivors die before hospital discharge or suffer significant neurological injury. Except for therape ...
Full textCite